{"id":11218,"date":"2022-11-23T09:13:14","date_gmt":"2022-11-23T08:13:14","guid":{"rendered":"https:\/\/ggba.swiss\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/"},"modified":"2023-07-04T13:44:08","modified_gmt":"2023-07-04T11:44:08","slug":"le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/","title":{"rendered":"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.opnabio.com\/\" target=\"_blank\" rel=\"noopener\">Opna Bio<\/a> est une soci\u00e9t\u00e9 biopharmaceutique de stade clinique ax\u00e9e sur la d\u00e9couverte et le d\u00e9veloppement de nouveaux traitements oncologiques. Le vaste portefeuille de la soci\u00e9t\u00e9 cible de multiples facteurs de cancer, y compris un nouveau programme de d\u00e9couverte oncologique ax\u00e9 sur la prot\u00e9ine de retard mental fragile-X (FMRP) et un portefeuille diversifi\u00e9 d&rsquo;actifs oncologiques valid\u00e9s acquis aupr\u00e8s de Plexxikon.<\/p>\n<p>Bas\u00e9e sur le campus des sciences de la vie <a href=\"https:\/\/www.biopole.ch\/\" target=\"_blank\" rel=\"noopener\">Biop\u00f4le<\/a> \u00e0 Epalinges (canton de Vaud), l&rsquo;\u00e9quipe d&rsquo;Opna Bio a fait ses preuves en mati\u00e8re d&rsquo;expertise scientifique et de cr\u00e9ation de valeur commerciale. Les membres de l&rsquo;\u00e9quipe ont d\u00e9j\u00e0 collabor\u00e9 avec des institutions prestigieuses telles que le Ludwig Institute for Cancer Research, l&rsquo;EPFL et la Yale University School of Medicine.<\/p>\n<p>Le tour de financement de s\u00e9rie A, d&rsquo;un montant de USD 38 millions, a \u00e9t\u00e9 men\u00e9 par <a href=\"https:\/\/www.longitudecapital.com\/\" target=\"_blank\" rel=\"noopener\">Longitude Capital<\/a> et <a href=\"https:\/\/www.npv.vc\/\" target=\"_blank\" rel=\"noopener\">Northpond Ventures<\/a>, avec une participation additionnelle de <a href=\"https:\/\/www.menlovc.com\/\" target=\"_blank\" rel=\"noopener\">Menlo Ventures<\/a>.<\/p>\n<h4>Un programme de d\u00e9couverte en oncologie bas\u00e9 sur des recherches de l&rsquo;EPFL<\/h4>\n<p>\u00ab\u00a0Je suis tr\u00e8s enthousiaste quant \u00e0 notre riche portefeuille de candidats m\u00e9dicaments, qui vise \u00e0 cibler la suppression immunitaire et d&rsquo;autres caract\u00e9ristiques du cancer\u00a0\u00bb, a d\u00e9clar\u00e9 Gideon Bollag, CEO d&rsquo;Opnia Bio. \u00ab\u00a0En tant que nouvelle soci\u00e9t\u00e9, Opna offre cette combinaison rare d&rsquo;une nouvelle cible m\u00e9dicamenteuse convaincante ainsi qu&rsquo;un pipeline diversifi\u00e9 de programmes pr\u00e9cliniques et cliniques, dont certains ont montr\u00e9 une activit\u00e9 combinatoire dans nos mod\u00e8les FMRP.\u00a0\u00bb<\/p>\n<p>Le lancement d&rsquo;Opna co\u00efncide avec une publication de Science du <a href=\"https:\/\/www.epfl.ch\/labs\/hanahan-lab\/\" target=\"_blank\" rel=\"noopener\">Laboratoire du Dr Hanahan \u00e0 l&rsquo;EPFL<\/a> sur le r\u00f4le \u00e9mergent de FMRP comme cible en immuno-oncologie. Le Dr Hanahan a d\u00e9montr\u00e9 pour la premi\u00e8re fois que le fait d&rsquo;assommer ou d&rsquo;\u00e9liminer le g\u00e8ne FMRP dans les cellules canc\u00e9reuses permet \u00e0 l&rsquo;organisme de lancer une r\u00e9ponse immunitaire contre des tumeurs qui sont autrement r\u00e9sistantes \u00e0 toute attaque immunitaire. Opna Bio dispose d&rsquo;une licence exclusive pour la technologie associ\u00e9e au FMRP de l&rsquo;EPFL.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Soci\u00e9t\u00e9 biopharmaceutique de stade clinique bas\u00e9e \u00e0 Lausanne, Opna Bio a lev\u00e9 USD 38 millions.<\/p>\n","protected":false},"author":3,"featured_media":11219,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1022,1041,1065,1068,1069],"class_list":["post-11218","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr","tag-financing-fr","tag-oncology-fr","tag-personalized-medicine-fr","tag-pharma-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"Soci\u00e9t\u00e9 biopharmaceutique de stade clinique bas\u00e9e \u00e0 Lausanne, Opna Bio a lev\u00e9 USD 38 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-23T08:13:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:44:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions\",\"datePublished\":\"2022-11-23T08:13:14+00:00\",\"dateModified\":\"2023-07-04T11:44:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/\"},\"wordCount\":365,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg\",\"keywords\":[\"Biotech\",\"Financing\",\"Oncology\",\"Personalized Medicine\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/\",\"name\":\"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg\",\"datePublished\":\"2022-11-23T08:13:14+00:00\",\"dateModified\":\"2023-07-04T11:44:08+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/","og_locale":"fr_FR","og_type":"article","og_title":"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions - Greater Geneva Bern area","og_description":"Soci\u00e9t\u00e9 biopharmaceutique de stade clinique bas\u00e9e \u00e0 Lausanne, Opna Bio a lev\u00e9 USD 38 millions.","og_url":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2022-11-23T08:13:14+00:00","article_modified_time":"2023-07-04T11:44:08+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions","datePublished":"2022-11-23T08:13:14+00:00","dateModified":"2023-07-04T11:44:08+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/"},"wordCount":365,"image":{"@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg","keywords":["Biotech","Financing","Oncology","Personalized Medicine","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/","url":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/","name":"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg","datePublished":"2022-11-23T08:13:14+00:00","dateModified":"2023-07-04T11:44:08+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Opna-Bio-630x380-1-2.jpg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/le-specialiste-des-therapies-oncologiques-opna-bio-leve-usd-38-millions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Le sp\u00e9cialiste des th\u00e9rapies oncologiques Opna Bio l\u00e8ve USD 38 millions"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=11218"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11218\/revisions"}],"predecessor-version":[{"id":18279,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11218\/revisions\/18279"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/11219"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=11218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=11218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=11218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}